This is a demo store. No orders will be fulfilled.

Amatuximab (anti-MSLN), 间皮素抑制剂

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
  • 亚型: Human IgG1
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab170485-100μg
100μg 现货 Stock Image
Ab170485-1mg
1mg 现货 Stock Image
Ab170485-5mg
5mg 现货 Stock Image
Ab170485-10mg
10mg 期货 Stock Image

基本信息

产品名称 Amatuximab (anti-MSLN), 间皮素抑制剂
别名 阿麦妥单抗 | 阿马妥昔单抗(抗 MSLN)
英文别名 Amatuximab | CAK 1 antibody | CAK1 antibody | CAK1 antigen antibody | cleaved form antibody | Megakaryocyte potentiating factorantibody | Mesothelin antibody | Mesothelin isoform 1 precursorantibody | MPF antibody | Msln antibody | MSLN_HUMAN antibody | P
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 MSLN
应用 ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
种属反应性 人(Human),小鼠(Mouse),食蟹猴(Cynomolgus monkey)
偶联 Unconjugated
作用类型 抑制剂
作用机制 间皮素抑制剂

产品属性

抗体类型 Primary antibody
克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 26.9 kDa (Light Chain) & 51.7 kDa (Heavy Chain), under reducing conditions; 175.6 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95%
来源 CHO supernatant
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 931402-35-6
分子类型 抗体

关联靶点(人)

MSLN Tbio 间皮素(Mesothelin) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Amatuximab (anti-MSLN) (Ab170485) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling MSLN (red) with Amatuximab (anti-MSLN) (Ab170485). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Amatuximab (anti-MSLN) (Ab170485) - SEC
The purity of Amatuximab (anti-MSLN) (Ab170485) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到5个结果

批号(Lot Number) 证书类型 货号
ZJ23F1101559 分析证书 Ab170485
ZJ23F1101558 分析证书 Ab170485
ZJ24F0911478 分析证书 Ab170485
ZJ24F0911477 分析证书 Ab170485
ZJ24F0911476 分析证书 Ab170485

引用文献

1. Hassan R, Ebel W, Routhier EL, Patel R, Kline JB, Zhang J, Chao Q, Jacob S, Turchin H, Gibbs L et al..  (2007)  Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin..  Cancer Immun,  (20).  [PMID:18088084]
2. Hassan R, Cohen SJ, Phillips M, Pastan I, Sharon E, Kelly RJ, Schweizer C, Weil S, Laheru D.  (2010)  Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers..  Clin Cancer Res,  16  (24): (6132-8).  [PMID:21037025]
3. Tang Z, Qian M, Ho M.  (2013)  The role of mesothelin in tumor progression and targeted therapy..  Anticancer Agents Med Chem,  13  (2): (276-80).  [PMID:22721387]
4. Ma J, Tang WK, Esser L, Pastan I, Xia D.  (2012)  Characterization of crystals of an antibody-recognition fragment of the cancer differentiation antigen mesothelin in complex with the therapeutic antibody MORAb-009..  Acta Crystallogr Sect F Struct Biol Cryst Commun,  68  (Pt 8): (950-3).  [PMID:22869130]
5. Hassan R, Kindler HL, Jahan T, Bazhenova L, Reck M, Thomas A, Pastan I, Parno J, O'Shannessy DJ, Fatato P et al..  (2014)  Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma..  Clin Cancer Res,  20  (23): (5927-36).  [PMID:25231400]
6. Kojima, T T and 6 more authors..  (1995)  Molecular cloning and expression of megakaryocyte potentiating factor cDNA..  The Journal of biological chemistry,  (15): [PMID:7665620]
7. Yamaguchi, N N and 5 more authors..  (1994)  A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5..  The Journal of biological chemistry,  (14): [PMID:8288629]
8. Chang, K K and Pastan, I I..  (1996)  Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers..  Proceedings of the National Academy of Sciences of the United States of America,  (9): [PMID:8552591]
9. Scholler, N N and 6 more authors..  (1999)  Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma..  Proceedings of the National Academy of Sciences of the United States of America,  (28): [PMID:10500211]
10. Daniels, R J RJ and 10 more authors..  (2001)  Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16..  Human molecular genetics,  (15): [PMID:11157797]
11. Rump, Armin A and 6 more authors..  (2004)  Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion..  The Journal of biological chemistry,  (5): [PMID:14676194]
12. Muminova, Zhanat E ZE, Strong, Theresa V TV and Shaw, Denise R DR..  (2004)  Characterization of human mesothelin transcripts in ovarian and pancreatic cancer..  BMC cancer,  (12): [PMID:15140265]
13. Martin, Joel J and 121 more authors..  (2004)  The sequence and analysis of duplication-rich human chromosome 16..  Nature,  (23): [PMID:15616553]
14. Ho, Mitchell M and 6 more authors..  (2005)  Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients..  Clinical cancer research : an official journal of the American Association for Cancer Research,  (15): [PMID:15897581]
15. Onda, Masanori M and 6 more authors..  (2006)  Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma..  Clinical cancer research : an official journal of the American Association for Cancer Research,  (15): [PMID:16857795]
16. Ma, Jichun J, Tang, Wai Kwan WK, Esser, Lothar L, Pastan, Ira I and Xia, Di D..  (2012)  Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights..  The Journal of biological chemistry,  (28): [PMID:22787150]
17. Tagliabracci, Vincent S VS and 14 more authors..  (2015)  A Single Kinase Generates the Majority of the Secreted Phosphoproteome..  Cell,  (18): [PMID:26091039]

溶液计算器